Vivaglobin: Clinical Trials

3 trials of Vivaglobin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 41Completed 1

Follow Vivaglobin: new trials by email Literature Review of Vivaglobin trials Research Report on Vivaglobin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Retrospective Chart Review of Subcutaneous IgG Use in Infants
Subcutaneous IgG (SCIG) - Primary Immune Deficiency
CompletedCSL Behring272010-05-012011-02-11
A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)
Vivaglobin - Multifocal Motor Neuropathy (MMN)
Phase 2CompletedCSL Behring82007-11-012013-08-01
Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency
Vivaglobin - Common Variable Immunodeficiency, Agammaglobulinemia
Phase 4CompletedCSL Behring182007-03-012013-06-20

Conditions studied

Primary Immunodeficiency Diseases (2)  ·  Agammaglobulinemia (1)  ·  Bruton type agammaglobulinemia (1)  ·  Common Variable Immunodeficiency (1)

Sponsors

CSL Behring (3)

Countries

Italy (2)  ·  Canada (1)  ·  Germany (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Bernd Kieseier, MD (1)  ·  Giancarlo Comi, MD (1)  ·  Matthias Sturzenegger, MD (1)  ·  Melvin Berger, MD, PhD (1)  ·  Michael Borte, MD (1)  ·  Siraj Misbah, MD (1)

Results publications

PMID 21692906, PMID 21932110